|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schutte K, Bornschein J and Malfertheiner
P: Hepatocellular carcinoma – epidemiological trends and risk
factors. Dig Dis. 27:80–92. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu AX: Systemic therapy of advanced
hepatocellular carcinoma: how hopeful should we be? Oncologist.
11:790–800. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Braun S, Vogl FD, Naume B, et al: A pooled
analysis of bone marrow micrometastasis in breast cancer. N Engl J
Med. 353:793–802. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pantel K, Izbicki J, Passlick B, et al:
Frequency and prognostic significance of isolated tumour cells in
bone marrow of patients with non-small-cell lung cancer without
overt metastases. Lancet. 347:649–653. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Natsugoe S, Nakashima S, Nakajo A, et al:
Bone marrow micrometastasis detected by RT-PCR in esophageal
squamous cell carcinoma. Oncol Rep. 10:1879–1883. 2003.PubMed/NCBI
|
|
7
|
Oki E, Kakeji Y, Baba H, et al: Clinical
significance of cytokeratin positive cells in bone marrow of
gastric cancer patients. J Cancer Res Clin Oncol. 133:995–1000.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mimori K, Fukagawa T, Kosaka Y, et al:
Hematogenous metastasis in gastric cancer requires isolated tumor
cells and expression of vascular endothelial growth factor
receptor-1. Clin Cancer Res. 14:2609–2616. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Calin GA and Croce CM: MicroRNA-cancer
connection: the beginning of a new tale. Cancer Res. 66:7390–7394.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hoshino I and Matsubara H: MicroRNAs in
cancer diagnosis and therapy: from bench to bedside. Surg Today.
43:467–478. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang P, Li QJ, Feng Y, et al:
TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment
promotes venous metastases of HBV-positive hepatocellular
carcinoma. Cancer Cell. 22:291–303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tomokuni A, Eguchi H, Tomimaru Y, et al:
miR-146a suppresses the sensitivity to interferon-α in
hepatocellular carcinoma cells. Biochem Biophys Res Commun.
414:675–680. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tomimaru Y, Eguchi H, Nagano H, et al:
Circulating microRNA-21 as a novel biomarker for hepatocellular
carcinoma. J Hepatol. 56:167–175. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tomimaru Y, Eguchi H, Nagano H, et al:
MicroRNA-21 induces resistance to the anti-tumour effect of
interferon-α/5-fluorouracil in hepatocellular carcinoma cells. Br J
Cancer. 103:1617–1626. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takeyama H, Yamamoto H, Yamashita S, et
al: Decreased miR-340 expression in bone marrow is associated with
liver metastasis of colorectal cancer. Mol Cancer Ther. 13:976–985.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Morimoto O, Nagano H, Miyamoto A, et al:
Association between recurrence of hepatocellular carcinoma and
α-fetoprotein messenger RNA levels in peripheral blood. Surg Today.
35:1033–1041. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Akiyoshi S, Fukagawa T, Ueo H, et al:
Clinical significance of miR-144-ZFX axis in disseminated tumour
cells in bone marrow in gastric cancer cases. Br J Cancer.
107:1345–1353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang MH, Chen CL, Chau GY, et al:
Comprehensive analysis of the independent effect of twist and snail
in promoting metastasis of hepatocellular carcinoma. Hepatology.
50:1464–1474. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmittgen TD, Jiang J, Liu Q and Yang L:
A high-throughput method to monitor the expression of microRNA
precursors. Nucleic Acids Res. 32:e432004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mori M, Mimori K, Inoue H, et al:
Detection of cancer micrometastases in lymph nodes by reverse
transcriptase-polymerase chain reaction. Cancer Res. 55:3417–3420.
1995.PubMed/NCBI
|
|
22
|
Yamamoto T, Nagano H, Sakon M, et al:
Partial contribution of tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to
antitumor effects of interferon-α/5-fluorouracil against
Hepatocellular Carcinoma. Clin Cancer Res. 10:7884–7895. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eguchi H, Nagano H, Yamamoto H, et al:
Augmentation of antitumor activity of 5-fluorouracil by interferon
α is associated with up-regulation of p27Kip1 in human
hepatocellular carcinoma cells. Clin Cancer Res. 6:2881–2890.
2000.PubMed/NCBI
|
|
24
|
Sakon M, Umeshita K, Nagano H, et al:
Clinical significance of hepatic resection in hepatocellular
carcinoma: analysis by disease-free survival curves. Arch Surg.
135:1456–1459. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jordan CT, Guzman ML and Noble M: Cancer
stem cells. N Engl J Med. 355:1253–1261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mani SA, Guo W, Liao MJ, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Aktas B, Tewes M, Fehm T, Hauch S, Kimmig
R and Kasimir-Bauer S: Stem cell and epithelial-mesenchymal
transition markers are frequently overexpressed in circulating
tumor cells of metastatic breast cancer patients. Breast Cancer
Res. 11:R462009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Raimondi C, Gradilone A, Naso G, et al:
Epithelial-mesenchymal transition and stemness features in
circulating tumor cells from breast cancer patients. Breast Cancer
Res Treat. 130:449–455. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kamiyama T, Takahashi M, Nakagawa T, et
al: AFP mRNA detected in bone marrow by real-time quantitative
RT-PCR analysis predicts survival and recurrence after curative
hepatectomy for hepatocellular carcinoma. Ann Surg. 244:451–463.
2006.PubMed/NCBI
|
|
31
|
Jiang A, Zhang S, Li Z, et al: miR-615-3p
promotes the phagocytic capacity of splenic macrophages by
targeting ligand-dependent nuclear receptor corepressor in
cirrhosis-related portal hypertension. Exp Biol Med (Maywood).
236:672–680. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Goswami RS, Atenafu EG, Xuan Y, et al:
MicroRNA signature obtained from the comparison of aggressive with
indolent non-Hodgkin lymphomas: potential prognostic value in
mantle-cell lymphoma. J Clin Oncol. 31:2903–2911. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cristofanilli M, Budd GT, Ellis MJ, et al:
Circulating tumor cells, disease progression, and survival in
metastatic breast cancer. N Engl J Med. 351:781–791. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fehm T, Muller V, Alix-Panabieres C and
Pantel K: Micrometastatic spread in breast cancer: detection,
molecular characterization and clinical relevance. Breast Cancer
Res. 10 (Suppl 1):S12008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ignatiadis M, Georgoulias V and Mavroudis
D: Micrometastatic disease in breast cancer: clinical implications.
Eur J Cancer. 44:2726–2736. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kota J, Chivukula RR, O'Donnell KA, et al:
Therapeutic microRNA delivery suppresses tumorigenesis in a murine
liver cancer model. Cell. 137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lanford RE, Hildebrandt-Eriksen ES, Petri
A, et al: Therapeutic silencing of microRNA-122 in primates with
chronic hepatitis C virus infection. Science. 327:198–201. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Soifer HS, Rossi JJ and Saetrom P:
MicroRNAs in disease and potential therapeutic applications. Mol
Ther. 15:2070–2079. 2007. View Article : Google Scholar : PubMed/NCBI
|
